EPI Update, April 22, 2011 by unknown
EPI Update for Friday, April 22, 2011 
Center for Acute Disease Epidemiology (CADE) 
Iowa Department of Public Health (IDPH) 
 
Items for this week’s EPI Update include 
 Measles update 
 Hantavirus testing 
 Health advice before international travel 
 Child and adolescent immunization schedule 
 Meeting announcements and training opportunities 
 
Measles update 
Minnesota continues to identify measles cases. As of Thursday, there have been 21 
confirmed cases with ages ranging from 4 months to 51 years old, 13 hospitalizations, 
and no deaths. This outbreak highlights the importance of measles immunizations prior 
to travel abroad. Seventeen of the cases have been linked to a case that was exposed 
to measles in Kenya, one exposed to measles in India, one in Florida, and one has an 
unknown source of exposure.  
 
In Iowa, a family was exposed to measles during an international flight returning from 
India. Home quarantine was put into place; fortunately, testing quickly determined that 
the family members were immune and quarantine was lifted less than 24 hours later. 
 
For instructions on follow-up of a possible measles patient, see the April 1 EPI Update 
at www.idph.state.ia.us/IdphArchive/Archive.aspx?channel=EpiUpdate. 
 
Hantavirus Testing 
Cases of Hantavirus Pulmonary Syndrome (HPS) rarely occur in Iowa. Infected rodents, 
such as deer mice, shed the virus in urine, droppings, and saliva. When the virus is 
aerosolized (droppings or nesting materials are stirred up), a person can be exposed by 
breathing the contaminated air. HPS can be diagnosed by serology testing looking for 
antibodies to the virus.  
 
Recently, three patients were told they had HPS based on a positive antibody 
test. Upon further investigation, the patients did NOT have HPS. The antibody test, 
performed by a commercial lab, is a “screening test” and is specifically designed to 
detect as many potential infections as possible. However, it lacks specificity, resulting in 
many false positive tests. Thus, any positive results from these screening tests must be 
confirmed for a definitive diagnosis. SHL offers a specific serology testing for Hantavirus 
which can serve as a confirmation for this commercial screening test. 
 
Health advice before international travel 
Seeking health advice prior to traveling abroad is recommended, including updating 
routine (“childhood”) immunizations, and assessing the need for non-routine 
immunizations and for preventive medications such as anti-malarial drugs. 
 
Clinicians can review the appropriate recommendations for their patients by using the 
newly updated “CDC Health Information for International Travel 2010” at 
wwwnc.cdc.gov/travel/content/yellowbook/home-2010.aspx, and for a health care 
checklist to share with your travelling patients, visit 
www.idph.state.ia.us/Cade/common/pdf/health_guidance_international_travel.pdf 
 
Child and adolescent immunization schedule 
With recent outbreaks of pertussis and measles highlighting the importance of 
vaccination, please note the updated child and adolescent immunization schedule for 
2011 is available at 
www.idph.state.ia.us/ImmTB/Immunization.aspx?prog=Imm&pg=Schedule. 
 
Changes in the schedule include:  
 Clarification of the hepatitis B vaccine schedule for children. 
 Recommendations on the use of 13-valent pneumococcal conjugate vaccine. 
 Clarification of the administration of one or two doses of seasonal influenza 
vaccine based upon the child’s history of monovalent 2009 H1N1 vaccination.  
 Use of tetanus and diphtheria toxoids, and acellular pertussis (Tdap) vaccine 
among children aged 7 through 10 years who are incompletely vaccinated 
against pertussis.  
 Reference to a specified interval between tetanus and diphtheria toxoids (Td) 
and Tdap vaccination has been removed.  
 A routine two-dose schedule of quadrivalent meningococcal conjugate vaccine 
(MCV4) for certain persons at high risk for meningococcal disease. 
Recommendations for a booster dose of MCV4 have been added.  
 Meeting announcements and training opportunities 
The Biosafety Laboratory Competencies.  
These competencies were released on April 14 as a result of the efforts of many 
very knowledgeable individuals around the country, including Iowa’s SHL. For 
more information, visit www.cdc.gov/mmwr/pdf/other/su6002.pdf. 
 
35th Iowa Infection Prevention and Control Seminar 
May 3 to 4, Gateway Hotel & Convention Center,  Ames, Iowa. The seminar  will 
cover infection control and patient safety issues. For more information, visit  
www.continuetolearn.uiowa.edu/UIconferences/. 
 
Have a healthy and happy week! 
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